Pralidoxime Comparative Effectiveness

Pralidoxime Comparative Effectiveness is a research construct in clinical pharmacology that evaluates the relative therapeutic outcomes of pralidoxime against alternative or adjunctive treatments for organophosphate poisoning, distinguished by its focus on efficacy, safety, and clinical utility across different dosing regimens, patient populations, and毒ological contexts.

8

Publications

401

Citations

38

Authors

17

Institutions

Publications per year

2017–2026

0

Authors

38

  1. GP
    Georg Petroianu

    United Arab Emirates University, United Arab Emirates

    3 publications · 102 citations

    3

    h-index

  2. SM
    Syed M. Nurulain

    United Arab Emirates University, United Arab Emirates

    3 publications · 102 citations

    3

    h-index

  3. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    2 publications · 82 citations

    2

    h-index

  4. JK
    Jiřı́ Kassa

    Jan Evangelista Purkyně Military Medical Academy, Czechia

    2 publications · 82 citations

    2

    h-index

  5. NN
    Nicolas Nagelkerke

    United Arab Emirates University, United Arab Emirates

    2 publications · 82 citations

    2

    h-index

1–5 of 38

Venues

  1. PubMed

    Repository · 2 publications · 52 citations

    2

    h-index

  2. Journal of Applied Toxicology

    2 publications · 76 citations

    2

    h-index

  3. Toxicological Sciences

    1 publications · 49 citations

    1

    h-index

  4. Saudi Journal of Anaesthesia

    1 publications · 29 citations

    1

    h-index

  5. Toxicology Mechanisms and Methods

    1 publications · 26 citations

    1

    h-index

1–5